Evidence map›Paper›PMID 31123062›Full record

ReviewGenes & development2019

PRC2 is high maintenance.

Jia-Ray Yu, Chul-Hwan Lee, Ozgur Oksuz, James M Stafford, Danny Reinberg

Abstract readReview
In one paragraph

Review in Genes & development, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Epigenetic regulation of kidney development.Nature reviews. Nephrology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. EPOP and MTF2 activate PRC2 activity through DNA-sequence specificity.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jia-Ray Yu *Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.ORCID 0000-0002-7080-4333
Chul-Hwan Lee *Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.ORCID 0000-0003-0643-0100
Ozgur Oksuz *Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.ORCID 0000-0001-8393-8501
James M StaffordDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.
Danny ReinbergDepartment of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, New York 10016, USA.ORCID 0000-0003-4288-2016

Funding

Repression via Facultative HeterochromatinR01CA199652 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI REINBERG, DANNY · 2015 to 2025
$4.2M
Understanding CTCF Boundaries Controlling Hox Gene ExpressionR01NS100897 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Esteban Orlando Mazzoni, DANNY REINBERG · 2018 to 2026
$4.1M
AUTS2 and the chromatin dynamics of alcohol use disordersK99AA024837 · NIAAA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI STAFFORD, JAMES M · 2017 to 2018
$328k
Howard Hughes Medical InstituteNCI NIH HHS R01 CA199652NIAAA NIH HHS K99 AA024837NINDS NIH HHS R01 NS100897
6 · The paper itself

Abstract

As the process that silences gene expression ensues during development, the stage is set for the activity of Polycomb-repressive complex 2 (PRC2) to maintain these repressed gene profiles. PRC2 catalyzes a specific histone posttranslational modification (hPTM) that fosters chromatin compaction. PRC2 also facilitates the inheritance of this hPTM through its self-contained "write and read" activities, key to preserving cellular identity during cell division. As these changes in gene expression occur without changes in DNA sequence and are inherited, the process is epigenetic in scope. Mutants of mammalian PRC2 or of its histone substrate contribute to the cancer process and other diseases, and research into these aberrant pathways is yielding viable candidates for therapeutic targeting. The effectiveness of PRC2 hinges on its being recruited to the proper chromatin sites; however, resolving the determinants to this process in the mammalian case was not straightforward and thus piqued the interest of many in the field. Here, we chronicle the latest advances toward exposing mammalian PRC2 and its high maintenance.

Indexed as

Epigenesis, GeneticGene Expression RegulationAnimalsChromatinHumansMutationNeoplasmsPolycomb Repressive Complex 2Protein TransportResearchChromatinPolycomb Repressive Complex 2chromatinepigeneticsPolycombPRC2

Identifiers

PMID31123062
PMCPMC6672058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.